WS #12528
Holding: newest synthesis is 52d 11h old
Novartis Q2 EPS $2.41 beats $2.13 estimate, sales $14.408B beat $14.042B estimate; reaffirms guidance. Trump imposes 50% tariffs on Canadian goods, escalating trade tensions; Canada vows to intensify talks.
Novartis earnings beat
Novartis Q2 EPS $2.41 beats $2.13 estimate, sales $14.408B beat $14.042B estimate; reaffirms guidance.
Trump imposes 50% tariffs on Canadian goods, escalating trade tensions; Canada vows to intensify talks.